New EU Clinical Trial Regulations simplify international trials while offering the means to counter drug shortages for trials ...

Deal numbers dropped in January this year compared to last, with outbound deals trumping inbound transactions.

The MSSG solidarity mechanism enables medicine sharing between EU states, with companies now required to report on drug ...

Vietnam is aiming to attract overseas investment to encourage domestic drug development through the amended 2016 Law on ...

Pfizer has ended the global commercialisation of its haemophilia B (factor IX deficiency) gene therapy Beqvez, citing soft ...

Clinical operations teams can expect a high return on investments in AI in the next 5–10 years, according to speakers at ...

The FDA has granted fast track designation to Pyxis oncology’s PYX-201 for the treatment of adults with R/M HNSCC.

IPA has entered a strategic partnership with Ribopro aiming to transform therapeutic antibody discovery and development.

Last month, the NICE endorsed Casgevy for use in the NHS under a managed access scheme to treat sickle cell disease.

Eli Lilly has announced plans to expand its domestic medicine production in the US with four new pharmaceutical manufacturing ...

Bridgene and Takeda have inked a deal worth $770m to develop small molecules for immunology and neurology.

Eli Lilly (Lilly) has agreed to make a $10m upfront payment for full worldwide rights to San Diego-based Organovo Holdings’ ...